These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9597990)

  • 21. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 22. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
    Katz J; Feldman MA; Bass EB; Lubomski LH; Tielsch JM; Petty BG; Fleisher LA; Schein OD;
    Ophthalmology; 2003 Sep; 110(9):1784-8. PubMed ID: 13129878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
    Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
    J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term anticoagulation or antiplatelet treatment. Inclusion criteria determine results of review.
    Mant J; Fitzmaurice D; Murray E; Lip GY; Hobbs FD
    BMJ; 2001 Jul; 323(7306):233-4; author reply 235-6. PubMed ID: 11496884
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 29. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 30. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
    Fisher M
    Stroke; 2009 May; 40(5):1944-5. PubMed ID: 19299634
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin and the risk of hemorrhagic stroke.
    Rosenberg R
    J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
    Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
    Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombosis prevention trial: follow-up study of practical implications.
    Fasey N; Brennan PJ; Meade TW;
    Br J Gen Pract; 2002 Mar; 52(476):208-9. PubMed ID: 12030663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin, aspirin, and atrial fibrillation.
    Harv Heart Lett; 1998 Aug; 8(12):4-6. PubMed ID: 9713234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.